MET Antikörper (N-Term)
MET
Reaktivität: Ratte
IF, ICC
Wirt: Kaninchen
Polyclonal
unconjugated
-
- Target Alle MET Antikörper anzeigen
- MET (Enkephalin (MET))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MET Antikörper ist unkonjugiert
-
Applikation
- Immunofluorescence (IF), Immunocytochemistry (ICC)
- Kreuzreaktivität
- Ratte (Rattus)
- Aufreinigung
- affinity purified
- Immunogen
- Synthetic Met-Enkephalin (H-Tyr-Gly-Gly-Phe-Met-OH) conjugated through N-terminal tyrosine to BSA.
- Isotyp
- IgG
- Top Product
- Discover our top product MET Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- RT
-
- Target
- MET (Enkephalin (MET))
- Andere Bezeichnung
- Met-Enkephalin (MET Produkte)
- Synonyme
- Enk antikoerper, Penk-rs antikoerper, Penk1 antikoerper, Penk2 antikoerper, proenkephalin antikoerper, PENK antikoerper, Penk antikoerper
- Hintergrund
- Met-enkephalin is a pentapeptide that appears to enhance immune function at low doses and suppresse at high doses. This molecule acts in the central nervous, neuroendocrine, and immune systems. Cells from these systems have receptors for met-enkephalin and are able to generate met enkephalin from its prohormone, proenkephalin A. Met-enkephalin may be capable of enhancing immune function in cancer or AIDS patients. It isknown to be an endogenous ligand for opioid receptors and acts to mediate analgesia at the spinal level. Met-enkaphalin. Plasma met enkaphalinlevelsaresignificantly higher in patients with type I diabetes and could play a role in glucose homeostasis. Cross-reactivity (%) Met5-Enkephalin100 , Leu5-Enkephalin 5. 8 , beta-Endorphin 0. 01 , beta-Lipotropin0. 01
-
Sie sind hier:
